Tehnoloģijas · 13.11.2026.1 min read

Sino Biological Launches 4RISE™ High-Throughput Wet-Lab Services to Accelerate AI-Driven Drug Discovery

Vietējais automātiskais tulkojums · Avota oriģinālvaloda

Illustration generated by Business News; it is not a source photograph.

Summary

HOUSTON, Nov. 13, 2026 — AI-designed protein binders require wet-lab validation to confirm their target-binding activity. Sino Biological, Inc.

Avota oriģinālvaloda: PR Newswire UK — News ReleasesAtvērt sākotnējo paziņojumu →

Related companies